TALK logo

Talkspace (TALK)

Profile

Full Name

Talkspace, Inc.

Ticker Symbol

TALK

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

July 30, 2020

Indexes

Not included

Website

http://www.talkspace.com

Employees

521

Key Details

Price

$2.73(-1.80%)

Market cap

$459.83M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$187.59M(+25.02% YoY)

Annual EPS

$0.01(+108.33% YoY)

PE ratio

379.17

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.73
TALK price is $2.73

30-Day Relative Volume

0.54
TALK 30-day relative volume is 0.54

Price Performance

Price Most recent change

-1.8%
TALK price was down -1.8% on Apr 16, 2025

Price YTD change

-11.65%
TALK price is down -11.65% since January 1st

Price 1-year change

-9.9%
TALK price is down -9.9% year-on-year

Price 3-year change

+56.9%
TALK price is up +56.9% over the past 3 years

Price Range

Price All-time high

$12.45
TALK price is currently -78.07% below its historical high of $12.45

Price 3-year low

$0.52
TALK price is currently +425.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$459.83M
TALK market capitalization is $459.83 million

Market cap 3-year change

+70.38%
TALK market capitalization is up +70.38% over the past 3 years

Market cap All-time high

$1.40B
TALK market capitalization is currently -67.14% below its historical high of $1.40 billion

Market cap sector rank

68.42%
TALK market capitalization is higher than 68.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.67%
TALK shares outstanding is down -0.67% year-on-year

Shares Outstanding 3-Year Change

+8.6%
TALK shares outstanding is up +8.6% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.05
TALK beta is 1.05

200-day SMA

$2.70
TALK price is currently +1.24% above its 200-day simple moving average

50-day SMA

$3.03
TALK price is currently -9.76% below its 50-day simple moving average

RSI

46.69
TALK 14-day relative strength index is 46.69

Volume

0.54
TALK 30-day relative volume is 0.54

ATR

$0.17
TALK average true range is $0.17

10-day Historical Volatility

61.81%
TALK 10-day historical volatility is 61.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$187.59M
TALK annual revenue is $187.59 million

Revenue Analysts estimate

$226.61M
TALK annual revenue is currently -17.22% lower than the consensus analysts' forecast

Revenue 1-year change

+25.02%
TALK annual revenue is up +25.02% year-on-year

Revenue Sector rank

63.13%
TALK annual revenue is higher than 63.13% of companies in Healthcare sector

EPS

EPS

$0.01
TALK annual earnings per share is $0.01

EPS Analysts estimate

-
TALK annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+108.33%
TALK annual earnings per share is up +108.33% year-on-year

EPS Sector rank

82.44%
TALK annual earnings per share is higher than 82.44% of companies in Healthcare sector

Profit

Gross profit

$85.84M
TALK annual gross profit is $85.84 million

Gross margin

45.76%
TALK annual gross profit margin is 45.76%

Operating profit

-$4.50M
TALK annual operating income is -$4.50 million

Operating margin

-2.40%
TALK annual operating profit margin is -2.40%

Net income

$1.15M
TALK annual net profit is $1.15 million

Net margin

0.61%
TALK annual net profit margin is 0.61%

Expenses

Total expenses

$192.09M
TALK annual total expenses is $192.09 million

Operating expenses

$90.33M
TALK annual total operating expenses is $90.33 million

Cost of goods sold

$101.76M
TALK annual cost of goods sold is $101.76 million

Selling, general & administrative expenses

$73.28M
TALK annual SGA is $73.28 million

Depreciation and amortization

$859.00K
TALK annual depreciation & amortization is $859.00 thousand

Interest expense

-
TALK annual interest expense value is unknown

Income tax

$94.00K
TALK annual income tax is $94.00 thousand

EBIT & EBITDA

EBIT

-$4.50M
TALK annual earnings before interest & taxes is -$4.50 million

EBITDA

-$3.64M
TALK annual EBITDA is -$3.64 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$138.68M
TALK annual total assets is $138.68 million

Non current assets

$8.49M
TALK annual long term assets is $8.49 million

Current assets

$130.18M
TALK annual total current assets is $130.18 million

Cash and cash equivalents

$76.69M
TALK annual cash & cash equivalents is $76.69 million

Accounts receivable

$9.64M
TALK annual accounts receivable is $9.64 million

Inventory

-
TALK annual inventory value is unknown

Liabilities

Total liabilities

$21.28M
TALK annual total liabilities is $21.28 million

Long term liabilities

$2.26M
TALK annual total long term liabilities is $2.26 million

Current liabilities

$19.02M
TALK annual total current liabilities is $19.02 million

Accounts payable

$7.71M
TALK annual accounts payable is $7.71 million

Debt

Total debt

$0.00
TALK annual total debt is $0.00

Total debt 1-year change

0%
TALK {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
TALK annual long term debt value is unknown

Short term debt

-
TALK annual short term debt value is unknown

Equity & Capital

Shareholders equity

$117.39M
TALK annual stockholders equity is $117.39 million

Book value

$117.39M
TALK annual book value is $117.39 million

Retained earnings

-$269.24M
TALK annual retained earnings is -$269.24 million

Working capital

$111.16M
TALK annual working capital is $111.16 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$11.70M
TALK annual cash flow from operations is $11.70 million

Cash from operations 1-year change

+171.4%
TALK annual cash flow from operations is up +171.4% year-on-year

Cash from investing

-$46.73M
TALK annual cash flow from investing activities is -$46.73 million

Cash from investing 1-year change

-33043.26%
TALK annual cash flow from investing activities is down -33043.26% year-on-year

Cash from financing

-$12.19M
TALK annual cash flow from financing activities is -$12.19 million

Cash from financing 1-year change

-742.49%
TALK annual cash flow from financing activities is down -742.49% year-on-year

CAPEX

CAPEX

$5.44M
TALK annual capital expenditures is $5.44 million

CAPEX 1-year change

+3504.64%
TALK annual capital expenditures is up +3504.64% year-on-year

Free Cash Flow

Free cash flow

$6.26M
TALK annual free cash flow is $6.26 million

Free cash flow 1-year change

+137.84%
TALK annual free cash flow is up +137.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.76%
TALK annual gross profit margin is 45.76%

Operating margin

-2.40%
TALK annual operating profit margin is -2.40%

Net margin

0.61%
TALK annual net profit margin is 0.61%

ROA & ROE

ROA

0.82%
TALK annual return on assets is 0.82%

ROE

0.97%
TALK annual return on equity is 0.97%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

379.17
TALK price to earnings ratio is 379.17

PE ratio Sector rank

98.04%
TALK price to earnings ratio is higher than 98.04% of companies in Healthcare sector

PB Ratio

PB ratio

3.92
TALK price to book ratio is 3.92

PB ratio Sector rank

79.09%
TALK price to book ratio is higher than 79.09% of companies in Healthcare sector

PS Ratio

PS ratio

2.45
TALK price to sales ratio is 2.45

PS ratio Sector rank

47.05%
TALK price to sales ratio is higher than 47.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$383.14M
TALK enterprise value is $383.14 million

Enterprise value Sector rank

66.25%
TALK enterprise value is higher than 66.25% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-105.32
TALK EV/EBITDA is -105.32

EV/EBITDA Sector rank

1.22%
TALK EV/EBITDA is higher than 1.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.84
TALK annual current ratio is 6.84

Quick ratio

-
TALK annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TALK annual debt to equity ratio is 0.00

Interest coverage ratio

-
TALK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TALK piotroski f-score value is unknown

Altman Z-Score

12.45
TALK altman z-score is 12.45

Analyst ratings

Recent major analysts updates

Apr 3, 25 Canaccord Genuity
Buy
Feb 21, 25 Needham
Hold
Dec 9, 24 Keybanc
Overweight
Dec 4, 24 Mizuho
Outperform
Nov 20, 24 Northland Capital Markets
Outperform
Oct 30, 24 Needham
Hold
Oct 29, 24 Barclays
Equal-Weight
Aug 6, 24 Needham
Hold
Jul 1, 24 Needham
Hold
Feb 23, 24 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

TYRA logo
Tyra Biosciences (TYRA)
KURA logo
Kura Oncology (KURA)
SVA logo
Sinovac Biotech (SVA)
SAGE logo
Sage Therapeutics (SAGE)
Fortrea Holdings (FTRE)
Upstream Bio (UPB)
CCRN logo
Cross Country Healthcare (CCRN)
DNA logo
Ginkgo Bioworks Holdings (DNA)
CTKB logo
Cytek Biosciences (CTKB)
  • What is the ticker symbol for Talkspace?
  • Does Talkspace pay dividends?
  • What sector is Talkspace in?
  • What industry is Talkspace in?
  • What country is Talkspace based in?
  • When did Talkspace go public?
  • Is Talkspace in the S&P 500?
  • Is Talkspace in the NASDAQ 100?
  • Is Talkspace in the Dow Jones?
  • When was Talkspace's last earnings report?
  • When does Talkspace report earnings?
  • Should I buy Talkspace stock now?

What is the ticker symbol for Talkspace?

The ticker symbol for Talkspace is NASDAQ:TALK

Does Talkspace pay dividends?

No, Talkspace does not pay dividends

What sector is Talkspace in?

Talkspace is in the Healthcare sector

What industry is Talkspace in?

Talkspace is in the Health Information Services industry

What country is Talkspace based in?

Talkspace is headquartered in United States

When did Talkspace go public?

Talkspace's initial public offering (IPO) was on July 30, 2020

Is Talkspace in the S&P 500?

No, Talkspace is not included in the S&P 500 index

Is Talkspace in the NASDAQ 100?

No, Talkspace is not included in the NASDAQ 100 index

Is Talkspace in the Dow Jones?

No, Talkspace is not included in the Dow Jones index

When was Talkspace's last earnings report?

Talkspace's most recent earnings report was on Feb 20, 2025

When does Talkspace report earnings?

The next expected earnings date for Talkspace is May 7, 2025

Should I buy Talkspace stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page